drugset / Trial / NCT00079794
Iscar for Supplemental Care in Stage IV Lung Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study it to determine whether supplemental treatment with Iscar improves immune function and quality of life among Stage IV non-small cell lung carcinoma patients receiving conventional chemotherapy. Iscar is an herbal medicine made from the total plant extract of mistletoe. this preparation is already in use in Europe and its use in the US is likely to increase as cancer patients continue to seek alternative therapies.
Timeline
- Start
- 2001-09
- Primary completion
- 2004-02
- Completion
- 2004-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iscar | Traditional medicine (herbal / TCM) | — | — |